JAK inhibitors: A new dawn for oral therapies in inflammatory bowel diseases

Inflammatory bowel disease (IBD) is a chronic immune-mediated condition of the gastrointestinal tract that requires chronic treatment and strict surveillance. Development of new monoclonal antibodies targeting one or a few single cytokines, including anti-tumor necrosis factor agents, anti-IL 12/23...

Full description

Bibliographic Details

Published in:	Frontiers in Medicine
Main Authors:	Claudia Herrera-deGuise, Xavier Serra-Ruiz, Ernesto Lastiri, Natalia Borruel
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Subjects:	inflammatory bowel diseases JAK inhibitors treatment oral therapies small molecules
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1089099/full